Latest News about LXRX
Recent news which mentions LXRX
Lexicon Pharmaceuticals's Return On Capital Employed Overview
December 14, 2022
Tickers
LXRX
From Benzinga
Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study
November 15, 2022
Tickers
LXRX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
From Benzinga
More Than $40 Million Bet On This Penny Stock? Check Out These 3 Penny Stocks Insiders Are Buying
August 02, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
This Financial Services Is Trading Higher By Over 217%; Here Are 38 Stocks Moving Premarket
August 02, 2022
From Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
July 28, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
From Benzinga
From Benzinga
Lexicon Shares Jump 20 Percent Following Positive Results From Mid-Stage Diabetic Neuropathy Study
June 29, 2022
Tickers
LXRX
From Benzinga
From InvestorPlace
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.